Investigating NEGR1 as a novel treatment target in major depressive disorder

Responsabile scientifico: prof. Giorgini Rimondini Roberto

Ente finanziatore: Medicines Discovery Catapult (MDC)

Durata: 01/08/2023 - 31/01/2025